Pro PB5+
Natural health product licensed in Canada
- Licence holder
- Naka Herbs & Vitamins Ltd.
- NPN or DIN-HM
- 80083558
- Status
- Active licence
- Licence date
- 5 March 2018
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : LA-14 | 8 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 8 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. Lactis Source : B1-04 | 2.6 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. Lactis Source : Cellule entière | 2.6 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. Lactis Source : HN 019 | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. Lactis Source : Cellule entière | 1.8 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HN 001 | 2 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lactobacillus salivarius Source : Cellule entière | 1.6 Milliards d'UFC | Not calculated |
| Lactobacillus salivarius Source : LS-33 | 1.6 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
L-Glutamine, Stéarate de magnésium, Cellulose microcristalline, Gomme de gellane, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favourable gut flora. Reduces the risk of developing upper-respiratory tract illness in physically active adults. Reduces the duration of upper-respiratory tract illness in physically active adults. Reduces whole gut transit time/helps to accelerate intestinal transit time. Supports digestion by reducing transit time. Reduces frequency of functional gastrointestinal symptoms (e.g. constipation, irregularity, flatulence). Promote bowel movement. Helps provide gentle relief of constipation and/or irregularity. Helps restore and maintain healthy vaginal flora. Helps support vaginal health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083558
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.